Key Takeaways from Analyst
Growing prevalence of end-stage renal disease (ESRD) around the world can aid the market expansion. Rising geriatric population who are more prone to chronic kidney diseases can also boost demand for peritoneal dialysis treatments. However, factors like risk of peritonitis and mechanical failures associated with peritoneal dialysis poses threat to market players.
North America currently dominates the peritoneal dialysis market and is expected to retain its leading position due to availability of advanced dialysis products and rising healthcare spending in the U.S. and Canada. Within North America, the U.S. market holds the major share. Europe is also a prominent region and growing patient awareness about peritoneal dialysis therapies will support revenue growth in this region.
Asia Pacific region, especially China and India, presents lucrative opportunities and is projected to exhibit fastest growth over the forecast period. Increasing healthcare developments and improving reimbursement scenarios in developing Asian countries boosts the adoption of peritoneal dialysis therapies. Large dialysis dependent ESRD patient pool and rising healthcare expenditure drives the market growth.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients